Aduro Biotech (KDNY) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 12/01/20
Aduro Biotech (KDNY) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 10/29/20
Aduro Biotech (KDNY) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 10/16/20
Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement FinancingGlobeNewsWire • 10/05/20
Aduro Biotech Stockholders Approve Merger Agreement with Chinook TherapeuticsGlobeNewsWire • 10/01/20
Aduro Biotech Provides Business Update and Reports Second Quarter 2020 Financial ResultsGlobeNewsWire • 08/03/20
Aduro Biotech (ADRO) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/30/20
Aduro Biotech Announces First Patient Dosed in Phase 1 Study of BION-1301 in IgA NephropathyGlobeNewsWire • 06/24/20
Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapiesGeekWire • 06/05/20
Aduro Biotech Presents Nonclinical and Phase 1 Healthy Volunteer Data for BION-1301 at the 57th ERA-EDTA Virtual CongressGlobeNewsWire • 06/02/20
Aduro Biotech (ADRO) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 05/25/20
Is Aduro Biotech (ADRO) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 05/25/20
Aduro Biotech (ADRO) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 04/28/20
Aduro Biotech (ADRO) Down 3.1% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 04/08/20
Has Aduro Biotech (ADRO) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 04/01/20